Celllife Antigen test kit for home use (single pack/5 tests pack) Approved by the TGA, ARTG No: 375418 Australia stock pre-oder available now!

 

Testsealabs® COVID-19 Antigen Rapid Test

The fast and convenient solution for the Point

of Care. User friendly test with prefilled test tubes.

The COVID-19 Antigen Rapid Test Kit gives a result in ten minutes.

Our Covid-19 Testing Center open now!

– Rapid Antigen Test
– Full Lab PCR Test
Bookings at: www.citytest.ie
7/8 City Quay, Dublin 2, D02Y663
Tel: 01-6799242/089-2715259

What influence do mutations have on the reliability of the Testsealabs Antigen Rapid Test?
Find out more now

We are currently supplying over 200 medical entities

including hospital, pharmacies, COVID-19 testing centres in Germany and Ireland.

Home use self-test available now!

Simple to use COVID-19 Rapid Antigen Self Test with results in 15 minutes.
– CE Approved for self testing
– On EC approved antigen test list
– Free ROI Delivery in 2-3 days
– From 1.9 EUR EUR/Test

COVID-19 Antigen Rapid Test

With the Coronavirus Test Ordinance (TestV) of October 14, 2020, rapid tests represent a new pillar in the containment of the current COVID-19 pandemic. These tests can be carried out on site by trained professionals and identify the pathogen of COVID-19 and its antigens right after.

For this purpose, a nasopharyngeal swab is taken from the back of the nose (recommended) or throat area and applied to a test cassette. This works according to the lateral flow principle and shows within 10 to 15 minutes whether COVID-19 antigens could be detected in the sample.

  • CE certified and refundable test listed at the Federal Institute for Drugs and Medical Devices according to the Coronavirus Test Ordinance (TestV) under the number AT129 / 20 . Link
  • Implementation on site by medically trained staff,                                                                                                       Result after 10 to 15 minutes
  • Reliable exclusion of a Sars-CoV-2 infection with high accuracy
  • Can be performed as a nasopharynx and oropharynx smear
  • The test is developed as a Point of Care (POC). No equipment is required, all consumables are included
  • Reaction membrane from the German world market leader Sartorius AG.

97,6%       98,4%       98,1%

Sensitivity                Specificity                 Accuracy

97,6% Sensitivity

98,4% Specificity

98,1% Accuracy

What effect do mutations have on the reliability of the
Testsealabs COVID-19 Antigen Rapid Test?

Lately there have been frequent reports of mutations in SARS-CoV-2, the cause of COVID-19. In particular, a variant from England with potentially increased infectivity is in the foreground.

This raises the question of what effect such mutations have on the reliability of rapid tests and whether an infection with the English variant can also be detected.

According to the current status, detection is just as reliable as with other variants.

Read the manufacturer’s statement on this

Detect a SARS-CoV-2

infection successfully with Lateral Flow Assays

Lateral flow assays are highly selective immunochromatographic assays that work with colloidal gold probes (GICA). They are based on specific monoclonal antibodies and recombinant proteins as a capture reagent. These migrate along a reaction membrane and can thus make antigens visible in the sample.

Test Principle

Unlike an antibody test, the rapid antigen test can directly detect the causative agent of COVID-19, the coronavirus SARS-CoV-2. It detects the proteins of the virus (the antigens). These can be found in pharyngeal swabs when the virus is replicating there. The rapid antigen test is therefore similar to the PCR test, particularly sensitive in the initial phase of the infection. Similar to the PCR test, it can also indicate a virus infection before symptoms appear.

Data

Assay type

Lateral flow PoC test

Test type

Qualitatively

Sample material

Nasopharynx | Oropharynx 

Duration

10-15 minutes

Pack size

20 tests / 1 tests 

Temperature

4 – 30 ° C 

Durability

2 years

Sensitivity

97.6% 

Specificity

98.4%

Accuracy

98.1%

€3.95/ Test

All prices plus VAT and shipping
Ready for dispatch in 1-2 working days
Available from stock in Ireland

€3.95

€3.70

€3.50

€3.30

From €2.95 On demand

Due to the current delivery situation, longer delivery times may occur for larger orders.
However, these are a maximum of 14 days. Feel free to contact us directly to send you an individual offer.

Cellife

Unlike an antibody test, the rapid antigen test can directly detect the causative agentof COVID-19, the coronavirus SARS-CoV-2. Itdetects the proteins of the virus (theantigens). These can be found in pharyngeal swabswhen the virus is replicatingthere. The rapid antigen test is therefore similar to the PCR test, particularly sensitivein the initial phase of the infection. Similar to the PCR test, it can also indicate a virusinfection before symptoms appear.

Product Variants

Maximum cost efficiency
Maximum cost efficiency. This kit is aimed primarily at bulk consumers such as doctors, nursing homes and clinics that have a high throughput. The test kit consists of 20 rapid tests, swabs and a large buffer bottle.
Maximum Flexibility

Maximum flexibility. This kit is aimed primarily at consumers who do not want to carry out all tests at the same time or who want easier operation. The kit contains 20 rapid tests, swabs and 20 sample tubes that already contain the sample buffer.

Individual Outer Packaging

This product is aimed primarily at resellers or individual users. Each test kit consists of a single rapid test, swab and sample tube with pre-filled buffer.

Documents

Quality control

infection successfully with Lateral Flow Assays

As a manufacturer of in-vitro diagnostics, seamless quality assurance is a matter of course for us. In addition, all processes that contribute to development and production are certified according to ISO13485 by TÜV Süd. Furthermore, all management processes are certified according to ISO9001 in order to offer the best possible quality. All products are CE compliant and are sold worldwide.
Please contact us if you want to find out more about the quality assurance of our products.

Detect a SARS-CoV-2 infection successfully with Lateral Flow Assays

Lateral flow assays are immunochromatographic, highly selective assays that work with colloidal gold probes (GICA). They are developed as a capture reagent based on unique monoclonal antibodies and recombinant proteins. These move along a reaction membrane and thus may make the sample visible to antigens.
antigen test kit
apid antigen test procedure

Test Principle

The rapid antigen test will directly detect the causative agent of COVID-19, the SARS-CoV-2 coronavirus, unlike an antibody test. This detects the virus proteins (the antigens). When the virus is replicating there, these can be contained in pharyngeal swabs.
Therefore, the rapid antigen test is similar to the PCR test, which is especially sensitive in the initial infection process. It may also suggest a virus infection before symptoms occur, similar to the PCR test.